世界の調剤薬局市場2023-2027

【英語タイトル】Global Compounding Pharmacy Market 2023-2027

Technavioが出版した調査資料(IRTNTR74609-23)・商品コード:IRTNTR74609-23
・発行会社(調査会社):Technavio
・発行日:2023年6月
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

調剤薬局の世界市場 2023-2027
調剤薬局市場は2022-2027年に1,682.04百万ドルの成長が予測され、予測期間中のCAGRは2.18%で加速すると予測されています。当レポートでは、調剤薬局市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25の企業を網羅した企業分析も提供しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、配合薬の需要を煽るHRTの人気の高まり、ホルモンバランスの問題の有病率の増加、政府の規制やイニシアチブによって牽引されています。

Technavioの調剤薬局市場は以下のように区分されます:

製品別
- 外用薬
- 経口薬
- 非経口薬
- その他の医薬品

治療領域別
- 疼痛管理
- ホルモン補充
- 皮膚疾患
- その他の治療領域

地域別
- 北米
- 米国
- カナダ
- 欧州
- 英国
- ドイツ
- フランス
- その他のヨーロッパ
- アジア
- 中国
- インド
- オーストラリア
- オーストラリア
- アルゼンチン
- その他の地域

本調査では、個別化医薬品の人気の高まりが、今後数年間の調剤薬局市場の成長を促進する主な理由の1つであると特定しています。また、新興市場における未開拓のビジネスチャンスや、世界的な必須医薬品の不足は、市場の大きな需要につながるでしょう。

本レポートでは、調剤薬局市場について以下の分野をカバーしています:
- 調剤薬局市場のサイジング
- 調剤薬局市場の予測
- 調剤薬局市場の業界分析

本レポートでは、クライアントが市場での地位を向上できるよう、しっかりとした企業分析を行い、ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. など、調剤薬局市場の主要企業の詳細な分析を掲載しています。また、調剤薬局市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立ちます。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場および企業状況が含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密な企業選定方法と分析を掲載しています。

1. エグゼクティブサマリー
2. 市場概況
3. 市場規模
4. 過去の市場規模
5. ファイブフォース分析
6. 調剤薬局の世界市場:製品別
7. 調剤薬局の世界市場:治療領域別
8. 顧客状況
9. 地域別状況
10. 推進要因・課題・動向
11. 企業状況
12. 企業分析
13. 付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Therapeutic Area
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global compounding pharmacy market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global compounding pharmacy market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Therapeutic Area Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Therapeutic Area Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Topical medications – Market size and forecast 2022-2027
o Exhibit 34: Chart on Topical medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Topical medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Topical medications – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Topical medications – Year-over-year growth 2022-2027 (%)
o 6.4 Oral medications – Market size and forecast 2022-2027
o Exhibit 38: Chart on Oral medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Oral medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Oral medications – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Oral medications – Year-over-year growth 2022-2027 (%)
o 6.5 Parenteral medications – Market size and forecast 2022-2027
o Exhibit 42: Chart on Parenteral medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Parenteral medications – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Parenteral medications – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Parenteral medications – Year-over-year growth 2022-2027 (%)
o 6.6 Others – Market size and forecast 2022-2027
o Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ million)
o Exhibit 51: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Therapeutic Area
o 7.1 Market segments
o Exhibit 52: Chart on Therapeutic Area – Market share 2022-2027 (%)
o Exhibit 53: Data Table on Therapeutic Area – Market share 2022-2027 (%)
o 7.2 Comparison by Therapeutic Area
o Exhibit 54: Chart on Comparison by Therapeutic Area
o Exhibit 55: Data Table on Comparison by Therapeutic Area
o 7.3 Pain management – Market size and forecast 2022-2027
o Exhibit 56: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Pain management – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
o 7.4 Hormone replacement – Market size and forecast 2022-2027
o Exhibit 60: Chart on Hormone replacement – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Hormone replacement – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Hormone replacement – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Hormone replacement – Year-over-year growth 2022-2027 (%)
o 7.5 Dermal disorders – Market size and forecast 2022-2027
o Exhibit 64: Chart on Dermal disorders – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Dermal disorders – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Dermal disorders – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Dermal disorders – Year-over-year growth 2022-2027 (%)
o 7.6 Others – Market size and forecast 2022-2027
o Exhibit 68: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Therapeutic Area
o Exhibit 72: Market opportunity by Therapeutic Area ($ million)
o Exhibit 73: Data Table on Market opportunity by Therapeutic Area ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 France – Market size and forecast 2022-2027
o Exhibit 103: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 107: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 111: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ million)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Advance Pharmacy
o Exhibit 123: Advance Pharmacy – Overview
o Exhibit 124: Advance Pharmacy – Product / Service
o Exhibit 125: Advance Pharmacy – Key offerings
o 12.4 Athenex Inc.
o Exhibit 126: Athenex Inc. – Overview
o Exhibit 127: Athenex Inc. – Product / Service
o Exhibit 128: Athenex Inc. – Key offerings
o 12.5 B.Braun SE
o Exhibit 129: B.Braun SE – Overview
o Exhibit 130: B.Braun SE – Business segments
o Exhibit 131: B.Braun SE – Key news
o Exhibit 132: B.Braun SE – Key offerings
o Exhibit 133: B.Braun SE – Segment focus
o 12.6 Fagron NV
o Exhibit 134: Fagron NV – Overview
o Exhibit 135: Fagron NV – Business segments
o Exhibit 136: Fagron NV – Key news
o Exhibit 137: Fagron NV – Key offerings
o Exhibit 138: Fagron NV – Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 139: Fresenius SE and Co. KGaA – Overview
o Exhibit 140: Fresenius SE and Co. KGaA – Business segments
o Exhibit 141: Fresenius SE and Co. KGaA – Key news
o Exhibit 142: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 143: Fresenius SE and Co. KGaA – Segment focus
o 12.8 Institutional Pharmacy Solutions
o Exhibit 144: Institutional Pharmacy Solutions – Overview
o Exhibit 145: Institutional Pharmacy Solutions – Product / Service
o Exhibit 146: Institutional Pharmacy Solutions – Key offerings
o 12.9 ITC Compounding Pharmacy
o Exhibit 147: ITC Compounding Pharmacy – Overview
o Exhibit 148: ITC Compounding Pharmacy – Product / Service
o Exhibit 149: ITC Compounding Pharmacy – Key offerings
o 12.10 McGuff Co. Inc.
o Exhibit 150: McGuff Co. Inc. – Overview
o Exhibit 151: McGuff Co. Inc. – Product / Service
o Exhibit 152: McGuff Co. Inc. – Key offerings
o 12.11 Nephron Pharmaceuticals Corp.
o Exhibit 153: Nephron Pharmaceuticals Corp. – Overview
o Exhibit 154: Nephron Pharmaceuticals Corp. – Product / Service
o Exhibit 155: Nephron Pharmaceuticals Corp. – Key offerings
o 12.12 Olympia Pharmacy
o Exhibit 156: Olympia Pharmacy – Overview
o Exhibit 157: Olympia Pharmacy – Product / Service
o Exhibit 158: Olympia Pharmacy – Key offerings
o 12.13 PenCol Specialty Pharmacy
o Exhibit 159: PenCol Specialty Pharmacy – Overview
o Exhibit 160: PenCol Specialty Pharmacy – Product / Service
o Exhibit 161: PenCol Specialty Pharmacy – Key offerings
o 12.14 Rx3 Compounding Pharmacy
o Exhibit 162: Rx3 Compounding Pharmacy – Overview
o Exhibit 163: Rx3 Compounding Pharmacy – Product / Service
o Exhibit 164: Rx3 Compounding Pharmacy – Key offerings
o 12.15 Triangle Compounding Pharmacy
o Exhibit 165: Triangle Compounding Pharmacy – Overview
o Exhibit 166: Triangle Compounding Pharmacy – Product / Service
o Exhibit 167: Triangle Compounding Pharmacy – Key offerings
o 12.16 Valor Compounding Pharmacy
o Exhibit 168: Valor Compounding Pharmacy – Overview
o Exhibit 169: Valor Compounding Pharmacy – Product / Service
o Exhibit 170: Valor Compounding Pharmacy – Key offerings
o 12.17 Wedgewood Village Pharmacy LLC
o Exhibit 171: Wedgewood Village Pharmacy LLC – Overview
o Exhibit 172: Wedgewood Village Pharmacy LLC – Product / Service
o Exhibit 173: Wedgewood Village Pharmacy LLC – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Therapeutic Area
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global compounding pharmacy market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Therapeutic Area Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Topical medications – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Topical medications – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Topical medications – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Topical medications – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Oral medications – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Oral medications – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Oral medications – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Oral medications – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Parenteral medications – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Parenteral medications – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Parenteral medications – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Parenteral medications – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Data Table on Market opportunity by Product ($ million)
Exhibits52: Chart on Therapeutic Area – Market share 2022-2027 (%)
Exhibits53: Data Table on Therapeutic Area – Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Therapeutic Area
Exhibits55: Data Table on Comparison by Therapeutic Area
Exhibits56: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Hormone replacement – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Hormone replacement – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Hormone replacement – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Hormone replacement – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Dermal disorders – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Dermal disorders – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Dermal disorders – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Dermal disorders – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Therapeutic Area ($ million)
Exhibits73: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ million)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Advance Pharmacy – Overview
Exhibits124: Advance Pharmacy – Product / Service
Exhibits125: Advance Pharmacy – Key offerings
Exhibits126: Athenex Inc. – Overview
Exhibits127: Athenex Inc. – Product / Service
Exhibits128: Athenex Inc. – Key offerings
Exhibits129: B.Braun SE – Overview
Exhibits130: B.Braun SE – Business segments
Exhibits131: B.Braun SE – Key news
Exhibits132: B.Braun SE – Key offerings
Exhibits133: B.Braun SE – Segment focus
Exhibits134: Fagron NV – Overview
Exhibits135: Fagron NV – Business segments
Exhibits136: Fagron NV – Key news
Exhibits137: Fagron NV – Key offerings
Exhibits138: Fagron NV – Segment focus
Exhibits139: Fresenius SE and Co. KGaA – Overview
Exhibits140: Fresenius SE and Co. KGaA – Business segments
Exhibits141: Fresenius SE and Co. KGaA – Key news
Exhibits142: Fresenius SE and Co. KGaA – Key offerings
Exhibits143: Fresenius SE and Co. KGaA – Segment focus
Exhibits144: Institutional Pharmacy Solutions – Overview
Exhibits145: Institutional Pharmacy Solutions – Product / Service
Exhibits146: Institutional Pharmacy Solutions – Key offerings
Exhibits147: ITC Compounding Pharmacy – Overview
Exhibits148: ITC Compounding Pharmacy – Product / Service
Exhibits149: ITC Compounding Pharmacy – Key offerings
Exhibits150: McGuff Co. Inc. – Overview
Exhibits151: McGuff Co. Inc. – Product / Service
Exhibits152: McGuff Co. Inc. – Key offerings
Exhibits153: Nephron Pharmaceuticals Corp. – Overview
Exhibits154: Nephron Pharmaceuticals Corp. – Product / Service
Exhibits155: Nephron Pharmaceuticals Corp. – Key offerings
Exhibits156: Olympia Pharmacy – Overview
Exhibits157: Olympia Pharmacy – Product / Service
Exhibits158: Olympia Pharmacy – Key offerings
Exhibits159: PenCol Specialty Pharmacy – Overview
Exhibits160: PenCol Specialty Pharmacy – Product / Service
Exhibits161: PenCol Specialty Pharmacy – Key offerings
Exhibits162: Rx3 Compounding Pharmacy – Overview
Exhibits163: Rx3 Compounding Pharmacy – Product / Service
Exhibits164: Rx3 Compounding Pharmacy – Key offerings
Exhibits165: Triangle Compounding Pharmacy – Overview
Exhibits166: Triangle Compounding Pharmacy – Product / Service
Exhibits167: Triangle Compounding Pharmacy – Key offerings
Exhibits168: Valor Compounding Pharmacy – Overview
Exhibits169: Valor Compounding Pharmacy – Product / Service
Exhibits170: Valor Compounding Pharmacy – Key offerings
Exhibits171: Wedgewood Village Pharmacy LLC – Overview
Exhibits172: Wedgewood Village Pharmacy LLC – Product / Service
Exhibits173: Wedgewood Village Pharmacy LLC – Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations



★調査レポート[世界の調剤薬局市場2023-2027] (コード:IRTNTR74609-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の調剤薬局市場2023-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆